---
title: "Bailouts vs. Suspensions: Hong Kong's Forgotten Stocks in Turmoil"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/302535091.md"
description: "China Taiping (0966.HK) secured HKD 7 billion state capital injection while MicroPort (0853.HK) remains suspended over lease dispute. Gu Ming (1364.HK) weathered tax-related volatility, Harbour BioMed (2142.HK) repurchased HKD 270 million. Sector divergence highlights how operational transparency increasingly dictates capital allocation in fragmented market."
datetime: "2026-10-21T09:17:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/302535091.md)
  - [en](https://longbridge.com/en/news/302535091.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/302535091.md)
generator: "portal-rs"
---

# Bailouts vs. Suspensions: Hong Kong's Forgotten Stocks in Turmoil

Hong Kong's 'other' sector reveals stark contrasts between state-backed resilience and governance fragility. China Taiping (0966.HK) secured regulatory approval for a HKD 7 billion capital injection—the first insurer 纳入 special treasury bond framework—though Q3 earnings face headwinds from equity market volatility. MicroPort Medical (0853.HK) remains suspended for seven weeks amid shareholder demands for an independent probe into its HKD 1.258 billion property lease transaction, with founder Chang Zhaohua's resignation amplifying concerns.

Gu Ming Tea (1364.HK) weathered a 11.4% intraday plunge after margin financing moves tied to tax payments, though Goldman Sachs maintained 'buy' citing 44.4% adjusted profit growth. Blocky (0325.HK) gained 4.03% weekly after debuting 500 new products at Wonder Festival Shanghai, outperforming despite broader weakness. Harbour BioMed (2142.HK) repurchased HKD 270 million over five days even as GIC trimmed stake to 7.95%.

New World Development (1686.HK) dropped 6.81% on weak data center sentiment, while CRRC Times Electric (3898.HK) secured rail contracts and attracted FIL Limited's 增持 to 5% stake. Jinyi Group (0565.HK) sold subsidiaries for nominal fees amid profit warnings, Free Gold (6228.HK) tumbled 12.88% on U.S. PPI data, and Perfect Medical (1830.HK) reshuffled its board. Operational transparency increasingly dictates survival in this fragmented landscape.

### Related Stocks

- [01364.HK](https://longbridge.com/en/quote/01364.HK.md)
- [00966.HK](https://longbridge.com/en/quote/00966.HK.md)
- [06228.HK](https://longbridge.com/en/quote/06228.HK.md)
- [01686.HK](https://longbridge.com/en/quote/01686.HK.md)
- [03898.HK](https://longbridge.com/en/quote/03898.HK.md)
- [00565.HK](https://longbridge.com/en/quote/00565.HK.md)
- [00853.HK](https://longbridge.com/en/quote/00853.HK.md)
- [02142.HK](https://longbridge.com/en/quote/02142.HK.md)
- [00325.HK](https://longbridge.com/en/quote/00325.HK.md)
- [01830.HK](https://longbridge.com/en/quote/01830.HK.md)

## Related News & Research

- [Harbour BioMed Announces NMPA Acceptance of IND Application for Its First AI-Enabled Drug Candidate LET003 for the Treatment of Overweight or Obesity](https://longbridge.com/en/news/306032412.md)
- [Harbour BioMed Appoints Dr. Sanjay Keswani as Scientific Advisor in Neuroscience](https://longbridge.com/en/news/305766056.md)
- [Merdeka Gold Delivers Strong Q2 Production Ramp-Up as Pani Gold Mine Advances Toward Full-year Growth](https://longbridge.com/en/news/297252362.md)
- [Harbour BioMed Stock In Focus After China Approval For Myasthenia Gravis Drug](https://longbridge.com/en/news/304427592.md)
- [Bloks Group controlling shareholder sells HK$ 251.26 million in shares](https://longbridge.com/en/news/302617210.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**